YAP1 and invasive breast carcinoma: In addition, analysis of a dataset of 887 patients with invasive breast carcinoma showed that coreduction of CTNNB1 (Wnt) and YAP1 (YAP) protein expression was correlated with improved patients’ survival (Fig. 6G, median survival of 140.18 months versus 74.67 months in the unaltered control).